Hydrogenology
Hydrogenology editorial study record

Peripheral endothelial function can be improved by daily consumption of water containing over 7 ppm of dissolved hydrogen: A randomized controlled trial

Ishibashi T et al. · PLoS One. 2020;15(5):e0233484.

HumanH₂-rich waterPublished 2020
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Randomized placebo-controlled parallel trial

Research topic

Cardiovascular and circulatory health

Administration classification

H₂-rich water

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Healthy adult volunteers

Sample

68 randomized: H₂ water n=34 and placebo n=34

Duration

Single-dose measures through 24 hours and daily intake for 14 days

Intervention

500 mL/day high-concentration hydrogen-rich water

Hydrogen form

H₂ dissolved in water — H₂ only, not Brown’s gas.

H₂ specification

7 ppm dissolved H₂; 3.5 mg H₂ in 500 mL water.

H₂ flow

Not applicable — oral water, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

500 mL/day nitrogen-containing placebo water

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Reactive hyperemia index measured by peripheral arterial tonometry

Reported result

The article reports greater Ln_RHI improvement with H₂ water, including 22.2% at 24 hours and 25.4% after two weeks. This is a physiological surrogate outcome, not a cardiovascular-event endpoint.

Results-extraction completeness

Dose, methods, full results, funding and competing-interest statements checked in the open-access full text; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Healthy-volunteer study with a surrogate vascular measure and short follow-up. The authors reported no specific funding.

Applies directly to

Healthy adults under the reported two-week drinking protocol; it does not establish prevention of cardiovascular events.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 32470022 · DOI: 10.1371/journal.pone.0233484

Publisher access

Open-access full text is available through PMC and PLOS.

Extraction basis

Open-access PMC and publisher full texts plus PubMed bibliographic record.

Record revision

2026-08-10